glp-1 obesity cardiovascular news Risks after Discontinuation Anti-obesity therapy for cardiovascular disease

Henry Meds includes a lab kit with care, and the Quest and Tasso partnerships cover most blood work needs at no extra charge for patients who want labs

Current clinical research has clearly demonstrated the strong link between LDL-C and CAC, particularly in individuals with chronically elevated LDL levels, where the risk of CAC progression is significantly increased [69, 70], and statin therapy has been demonstrated to decrease the volume of non-calcified plaques in addition to lowering LDL-C levels [71]

In the stomach, indole 3-carbinol must be broken down into its active metabolite diindolylmethane, another indole compound that also has similar health benefits

Owen, K